Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Jocelyn Bosse, Alessandro Cerri, Oliver Fairhurst and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Anastasiia Kyrylenko (Book Review Editor).

InternKats: Simone Lorenzi and Asude Sena Moya.
Results for patents
To infinity and beyond! The sufficiency requirements for open-ended ranges (T 1977/22) To infinity and beyond! The sufficiency requirements for open-ended ranges (T 1977/22) Reviewed by Dr Rose Hughes on Tuesday, March 04, 2025 Rating: 5
Never Too Late: If you missed the IPKat last week! Never Too Late: If you missed the IPKat last week! Reviewed by Simone Lorenzi on Tuesday, March 04, 2025 Rating: 5
CJEU clarifies jurisdiction rules for European patent enforcement: BSH Hausgeräte vs. Electrolux AB CJEU clarifies jurisdiction rules for European patent enforcement: BSH Hausgeräte vs. Electrolux AB Reviewed by Dr Rose Hughes on Friday, February 28, 2025 Rating: 5
Never Too Late: If you missed the IPKat last week! Never Too Late: If you missed the IPKat last week! Reviewed by Asude Sena Moya on Wednesday, February 26, 2025 Rating: 5
[Guest Post] UK SPCs: Clinging to nurse, or fear of something worse? (Merck v Comptroller [2025] EWCA Civ 45) [Guest Post] UK SPCs: Clinging to nurse, or fear of something worse? (Merck v Comptroller [2025] EWCA Civ 45) Reviewed by Dr Rose Hughes on Wednesday, February 26, 2025 Rating: 5
Review of AI patent drafting software for life sciences: Qatent Review of AI patent drafting software for life sciences: Qatent Reviewed by Dr Rose Hughes on Tuesday, February 25, 2025 Rating: 5
The benefits and pitfalls of drug manufacturing IP (T 2543/22) The benefits and pitfalls of drug manufacturing IP (T 2543/22) Reviewed by Dr Rose Hughes on Saturday, February 22, 2025 Rating: 5
Never Too Late: If you missed the IPKat last week! Never Too Late: If you missed the IPKat last week! Reviewed by Simone Lorenzi on Monday, February 17, 2025 Rating: 5
EBA's preliminary opinion in G1/24: "the description and the figures can be referred to in the course of claim interpretation" EBA's preliminary opinion in G1/24: "the description and the figures can be referred to in the course of claim interpretation" Reviewed by Dr Rose Hughes on Wednesday, February 12, 2025 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.